Physical activity, exercise benefit patients with lung cancer, survivors
the ONA take:
According to a new study published in the Journal of Thoracic Oncology, researchers at The Medical University of South Carolina in Charleston, South Carolina, have found that physical activity should be considered as a therapeutic option of patients with lung cancer as exercise and physical activity have been shown to reduce symptoms, improve quality of life, increase exercise tolerance, and decrease length of hospitalization and post-surgery complications for lung cancer.
The authors found that most patients with lung cancer want advice about physical activity from a cancer center physician before cancer therapy and exercise guidance may improve compliance with the use of a dedicated program. Another important finding was that exercise and physical activity are safe for those with lung cancer.
In addition, both patients with lung cancer and lung cancer survivors experienced the same benefits of increased activity, particularly improved symptoms and quality of life.
The authors conclude that health care professionals should consider physical activity early and encourage physical activity in patients any stage of lung cancer and lung cancer survivors.
Physical activity have been shown to reduce lung cancer symptoms, improve quality of life.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|